MTOR and laryngeal carcinoma: In this study, IGF‐1 treatment activated PI3K‐Akt‐mTOR signalling pathway, enlarged the resistance to radiotherapy, and elevated glucose uptake and the expression of HIF‐1α and Glut‐1 in laryngeal cancer cells.